Aspire Biopharma Holdings, Inc. (ASBP) › RevenueAspire Biopharma Holdings, Inc. (ASBP) — RevenueAnnual figures by fiscal year, from SEC filings.Fiscal YearRevenueChange YoY2025$6.2K—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share